Latest News
From the Journals
Denosumab on par with zoledronic acid for multiple myeloma bone disease
The results come from a phase 3 randomized trial of patients with newly diagnosed multiple myeloma with one or more lytic bone lesions.
From the Journals
Cutaneous multiple myeloma is a deadly indicator
The specific cutaneous manifestation is seen as waxy dome-shaped nodules with variable sizes in various locations.
Conference Coverage
JAK inhibitors for RA: Is VTE risk overblown?
MAUI, HAWAII – “Certainly we are seeing these events. The question is, ‘How overdone is this?’ ” said Mark C. Genovese, MD.
From the Journals
Cyclophosphamide extends PFS in elderly HER2+ breast cancer patients
Adding oral cyclophosphamide to trastuzumab and pertuzumab in frail elderly HER2-positive metastatic breast cancer patients improved median PFS by...
News
Allscripts’ charges for sending, refilling prescriptions
A company like Allscripts can charge doctors for services, but most doctors aren’t in a position to increase their prices, Dr. Allan M. Block says...
Feature
Opioids a focus as HHS Secretary Azar defends White House budget proposal
Mr. Azar said that the budget proposal “brings a new level of commitment to fighting the crisis of opioid addiction.”
News
FDA approves apalutamide for castration-resistant nonmetastatic prostate cancer
This is the first FDA approval based on the endpoint of metastasis-free survival.
Conference Coverage
A view from the bridge to transplant for PTCL
LA JOLLA, CALIF. – Subtype and timing matter when considering the best bridge to transplant.
Conference Coverage
The T-cell repertoire in NSCLC: Therapeutic implications
New findings regarding the T-cell repertoire in NSCLC patients could have implications for the use of TIL therapy, checkpoint blockade, and more...
From the Journals
Radiation exposure in MICU may exceed recommended limit
In a study of 4,155 patients admitted to a medical ICU, 1% accrued a cumulative effective dose of radiation of at least 100 mSv.
Feature
Colorectal cancer deaths projected for 2018
Estimates for each state put the lowest rate in Utah.